Krystal Biotech logo
Krystal Biotech KRYS
$ 163.39 1.59%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Krystal Biotech Financial Statements 2011-2024 | KRYS

Annual Financial Statements Krystal Biotech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

4.29 B 2 B 1.41 B 1.48 B 840 M 256 M 53.8 M - - - - - -

Shares

27.2 M 25.5 M 22.2 M 18.8 M 15.9 M 11.2 M 5.36 M - - - - - -

Historical Prices

158 78.3 63.5 78.9 53.5 22.4 10.1 - - - - - -

Net Income

10.9 M -140 M -69.6 M -32.2 M -19.1 M -10.9 M -7.92 M -1.15 M - - - - -

Revenue

50.7 M - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-110 M -145 M -68.3 M -33 M -22.1 M -11.9 M -4.77 M -1.14 M - - - - -

Interest Expense

- - 1.49 M - - - - - - - - - -

EBITDA

-105 M -143 M -66.4 M -31.1 M -21.3 M -11.8 M -4.75 M -1.14 M - - - - -

Operating Expenses

160 M 145 M 68.3 M 33 M 22.1 M 11.9 M 4.77 M - - - - - -

General and Administrative Expenses

98.4 M 77.7 M 40.4 M 15.1 M 6.46 M 4.16 M 1.56 M 402 K - - - - -

All numbers in USD currency

Quarterly Income Statement Krystal Biotech

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

28.7 M 28.6 M 28.3 M 28.2 M 28 M 26.7 M 25.7 M 25.8 M 25.6 M 25.5 M 25.1 M 25.2 M 22.2 M 22.2 M 21.3 M 19.7 M 19.7 M 18.4 M 17.4 M 17.4 M 17.3 M 14.5 M 14.4 M 14.4 M 10.6 M 10.3 M 10.3 M 10.3 M 4.18 M 3.49 M 3.49 M - 38 K - - - - - - - - - - - - - - - - - - - - - -

Net Income

27.2 M 15.6 M 932 K - 80.7 M -33.2 M -45.3 M - -29.8 M -28.1 M -50 M - -15.6 M -16.4 M -15.8 M - -9.61 M -6.83 M -5.34 M - -4.27 M -5.35 M -4.11 M - -2.76 M -2.28 M -2.15 M - -5.27 M -759 K -494 K - -322 K - - - - - - - - - - - - - - - - - - - - - -

Revenue

83.8 M 70.3 M 45.2 M - 8.56 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

22.4 M 8.57 M -6.68 M - -26 M -38 M -48.8 M - -31.5 M -28.8 M -50.2 M - -15.7 M -16.4 M -14.4 M - -9.68 M -6.95 M -5.95 M - -5.34 M -5.89 M -4.69 M - -2.97 M -2.45 M -2.28 M - -2.09 M -715 K -465 K - -322 K - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - 1.49 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

23.7 M 10.4 M -5.26 M - -24.8 M -36.8 M -47.7 M - -30.8 M -28.3 M -49.2 M - -13.7 M -15.2 M -13.8 M - -8.32 M -6.07 M -5.53 M - -4.59 M -5.44 M -4.56 M - -2.93 M -2.43 M -2.26 M - -2.09 M -712 K -464 K - -322 K - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

61.4 M 61.7 M 51.9 M - 34.5 M 38 M 48.8 M - 31.5 M 28.8 M 50.2 M - 15.7 M 16.4 M 14.4 M - 9.68 M 6.95 M 5.95 M - 5.34 M 5.89 M 4.69 M - 2.97 M 2.45 M 2.28 M - 2.09 M 715 K 465 K - 322 K - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

28.7 M 27.6 M 26.1 M - 23.7 M 25.9 M 24 M - 19.9 M 17.9 M 15.9 M - 9.57 M 9.8 M 8.15 M - 4.58 M 3.32 M 2.42 M - 1.46 M 1.67 M 1.53 M - 1.06 M 924 K 757 K - 738 K 269 K 146 K - 81 K - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency